Expert Hepatology & Liver Transplant FAQs
Dr Chetan Kalal, DM Hepatology
❓ Who should consult a hepatologist instead of a general physician or gastroenterologist?
Patients should consult a hepatologist when:
Liver disease is chronic, progressive, or recurrent
Cirrhosis is suspected or confirmed
Liver-related complications have occurred
Transplant timing needs evaluation
Prior treatment has failed or stalled
A hepatologist is trained specifically to manage disease trajectory and transplant decisions, not just liver enzymes.
❓ When should a second opinion be taken in liver disease?
A second opinion is warranted when:
The diagnosis is unclear or changing
Treatment is ongoing but outcomes are poor
“Wait and watch” is advised without a roadmap
Cirrhosis is labeled “stable”
Transplant has not been discussed despite deterioration
In liver disease, delay itself becomes a risk factor.
❓ Is “stable cirrhosis” a real medical condition?
No.
Cirrhosis is either compensated, decompensating, or silently progressing.
The term “stable cirrhosis” is a non-clinical label that often delays:
Risk stratification
Nutrition intervention
Transplant planning
Cirrhosis requires active surveillance and forward planning, even when symptoms are minimal.
❓ What are early signs that liver disease is worsening?
Early deterioration may occur before obvious symptoms and include:
Falling albumin
Rising INR
Progressive muscle loss
Increasing portal hypertension
Recurrent infections
Declining exercise tolerance
Waiting for jaundice or ascites often means the window for optimal intervention has narrowed.
❓ When should liver transplant be discussed?
Transplant should be discussed:
At first decompensation
When MELD/Child scores trend upward
Before kidney dysfunction develops
While nutrition and muscle mass are preserved
Late transplant discussions reduce eligibility and worsen outcomes.
Transplant timing is a hepatology decision, not a surgical one.
❓ Can fatty liver really progress to cirrhosis?
Yes.
Fatty liver disease (NAFLD / NASH / MAFLD) is now a leading cause of cirrhosis and liver transplant worldwide.
Progression is accelerated by:
Diabetes
Obesity
Alcohol
Genetic susceptibility
Normal enzymes do not rule out advanced disease.
❓ Are virtual hepatology consultations reliable?
Yes — when used correctly.
Virtual consults are effective for:
Second opinions
Report and imaging review
Post-transplant follow-up
Long-term cirrhosis management
Treatment planning before travel
They are not substitutes for emergency or ICU care.
❓ Who needs antiviral prophylaxis before chemotherapy or transplant?
Patients who are:
HBsAg negative but anti-HBc positive
Planned for chemotherapy, biologics, BMT, or transplant
These patients are at high risk of hepatitis B reactivation and require prophylactic antivirals even if HBV DNA is undetectable.
❓ Why do liver treatments fail despite regular follow-up?
Common reasons include:
Incorrect disease labeling
Fragmented care
Delayed escalation
Missed transplant windows
Focus on lab values instead of trends
Liver disease requires ownership and decisiveness, not passive monitoring.
❓ How is IPD hepatology different from OPD liver care?
IPD hepatology involves:
Daily trajectory assessment
Management of multi-organ interactions
Infection and renal risk anticipation
Real-time transplant decisions
OPD care cannot substitute for command-level inpatient hepatology during decompensation.
❓ Why do patients consult Dr Chetan Kalal for liver disease?
Dr Chetan Kalal is a DM-trained Hepatologist and Liver Transplant Physician with focused expertise in advanced liver disease, transplant timing, and failed treatment cases.
He is the First DM Hepatologist of Maharashtra, and is known for:
Decisive second opinions
Early identification of deterioration
Active, plan-driven cirrhosis care
Integrated IPD hepatology management
Patients seek clarity — not comfort.
❓ How can I book a consultation?
Appointments for OPD, IPD referrals, second opinions, and virtual consults can be scheduled at:
🌐 www.drchetankalal.com
